Ambalal Sarabhai Enterprises Limited
Ambalal Sarabhai Enterprises Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: AMBALALSA and BSE: 500009 (ISIN INE432A01017).
It has a market capitalisation of ₹295 crore, a last close of ₹38.51 on 2026-10-19.
Valuation: a price-to-earnings ratio of 16.58x, a price-to-book ratio of 1.86x, a dividend yield of 0.0%.
Profitability: return on equity of 11.9%, return on capital employed of 13.3%, an operating margin of 5.8%.
Growth: sales growth of 5.9% a year over three years, net profit growth of 17.1% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.33x.
| Metric | Value |
|---|---|
| Market capitalisation | 295 |
| Last close | ₹38.51 |
| P/E (TTM) | 16.58x |
| P/B | 1.86x |
| Dividend yield | 0.0% |
| ROE (FY) | 11.9% |
| ROCE (FY) | 13.3% |
| Operating margin (TTM) | 5.8% |
| Sales growth, 3-year CAGR | 5.9% |
| Profit growth, 3-year CAGR | 17.1% |
| Debt / equity | 0.33x |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means